Prevnar 13, the vaccine given to all children in the United States during infancy to prevent infections by the pneumococcus bacteria, is being studied for its effectiveness against new bacterial strains which become antibiotic resistant.
Michael Pichichero MD/Rochester General Health System studies the need for booster vaccines related to disease progression.
Study of potential risks to children when thimerosol, a mercury-based preservative, is used in childhood vaccines.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right